Publicaciones en las que colabora con Javier Pagonabarraga Mora (8)

2022

  1. Level I PD-MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia

    Movement Disorders Clinical Practice, Vol. 9, Núm. 4, pp. 479-483

2021

  1. Present and future of parkinson’s disease in Spain: Parkinson-2030 delphi project

    Brain Sciences, Vol. 11, Núm. 8

2020

  1. A Spanish consensus on the use of safinamide for parkinson’s disease in clinical practice

    Brain Sciences, Vol. 10, Núm. 3

  2. Erratum: A Spanish consensus on the use of safinamide for parkinson’s disease in clinical practice. (Brain sci. (2020) 10, 176)

    Brain Sciences

2019

  1. Safinamide in clinical practice: A Spanish multicenter cohort study

    Brain Sciences, Vol. 9, Núm. 10

2016

  1. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression

    BMC Neurology, Vol. 16, Núm. 1

2013

  1. Rasagiline in monotherapy in patients with early stages of Parkinson's disease and in combined and adjunct therapy to levodopa with moderate and advanced stages

    Revista de Neurologia, Vol. 56, Núm. 1, pp. 25-34

2009

  1. Homocysteine and cognitive impairment in Parkinson's disease: A biochemical, neuroimaging, and genetic study

    Movement Disorders, Vol. 24, Núm. 10, pp. 1437-1444